<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">SERTACONAZOLE NITRATE</span><br/>(ser-ta-con'a-zole)<br/><span class="topboxtradename">Ertaczo<br/></span><b>Classifications:</b> <span class="classification">antiinfective</span>; <span class="classification">antibiotic</span>; <span class="classification">azole antifungal</span><br/><b>Prototype: </b>Fluconazole<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>2% cream in 15 g and 30 g tubes<b></b>
</p>
<h1><a name="action">Actions</a></h1>
<p>Antifungal that belongs to the azole class of antifungals. While the exact mechanism of action of azole antifungals is not
         known, it is believed that they act primarily by inhibiting the cytochrome P450-dependent synthesis of ergosterol, a key component
         of the cell membrane of fungi resulting in fungal cell injury.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Active against the following organisms: <i>Trichophyton rubrum,</i>
<i>Trichophyton mentagrophytes,</i> and <i>Epidermophyton floccosum</i>.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Treatment of tinea pedis in immunocompetent patients.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Onychomycosis; children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>History of hypersensitivity to azole antifungals; lactation.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Tinea Pedis</span><br/><span class="rdage">Adult/Child:</span> <span class="rdroute">Topical</span>
<i>&gt;12 y,</i> Apply thin layer to affected area twice daily for 4 wk<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Topical</span><br/><ul>
<li>Cleanse the affected area and dry thoroughly before application.</li>
<li>Apply a thin layer of the cream to affected area between the toes and the immediately surrounding healthy skin. Gently rub
            into the skin.
         </li>
<li>Store at 15°30° C (57°86° F).</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Skin:</span> Contact dermatitis, dry skin, burning, application site reaction, skin tenderness. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption<b></b>
         			:</span> Negligible absorption through intact skin. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor for clinical improvement, which should be seen about 2 wk after initiating treatment.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Report any of the following: severe skin irritation, redness, burning, blistering, or itching.</li>
<li>Do not stop using this medication prematurely. Athlete's foot takes about 4 wk to clear completely.</li>
<li>Nursing mothers should ensure that this topical cream does not accidentally get on the breast.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>